| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |